Clinical Trials Sponsored by Annick Desjardins, MD
Total 12 results
-
Annick Desjardins, MDCelldex TherapeuticsActive, not recruitingGlioblastomaUnited States
-
Annick DesjardinsCompletedMalignant GliomaUnited States
-
Annick DesjardinsAstraZenecaCompletedGlioblastoma | GliosarcomaUnited States
-
Annick DesjardinsAmgenTerminated
-
Annick DesjardinsNovartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
Annick DesjardinsAmbit Biosciences CorporationCompleted
-
Annick DesjardinsAstraZeneca; Novartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
Annick DesjardinsSymphogen A/SCompletedMalignant GliomaUnited States
-
Annick DesjardinsTactical Therapeutics, Inc.TerminatedMalignant Glioma (WHO Grade III or IV)United States
-
Annick DesjardinsTactical Therapeutics, Inc.TerminatedMalignant Glioma (WHO Grade III or IV)United States
-
Annick DesjardinsBristol-Myers SquibbWithdrawnGlioma | Glioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic OligodendrogliomaUnited States
-
Brian Henick, MDRecruiting